Henry Schein Updates Strategic Partnership with KKR

Henry Schein ( (HSIC) ) has shared an update.

On May 2, 2025, Henry Schein, Inc. and KKR Hawaii Aggregator L.P. entered into a letter agreement to remove KKR’s voting commitment from their Strategic Partnership Agreement, while maintaining all other terms. Additionally, Max Lin was appointed to Henry Schein’s board of directors as an independent director, following the satisfaction of regulatory conditions. Lin, a partner at KKR, will serve on the Nominating and Governance Committee and the Strategic Advisory Committee, bringing extensive experience from his roles in healthcare and private equity.

Spark’s Take on HSIC Stock

According to Spark, TipRanks’ AI Analyst, HSIC is a Neutral.

Henry Schein exhibits a stable financial performance with strong cash flow and operational efficiency, although increased debt levels pose a risk. The technical analysis suggests a bearish trend, which is a concern. Valuation is moderate, and the recent earnings call and corporate partnership with KKR provide a balanced outlook with potential for modest growth. Overall, the stock presents a stable but cautious investment opportunity.

To see Spark’s full report on HSIC stock, click here.

More about Henry Schein

YTD Price Performance: -5.97%

Average Trading Volume: 1,877,494

Technical Sentiment Signal: Buy

Current Market Cap: $7.9B

Learn more about HSIC stock on TipRanks’ Stock Analysis page.